Carbonic anhydrase activation profile of indole-based derivatives

References

• Supuran CT. Structure and function of carbonic anhydrases. Biochem J 2016;473:2023–32.
   PubMed Web of Science ®Google Scholar
• Chesler M. Regulation and modulation of pH in the brain. Physiol Rev Am Physiol Soc 2003;83:1183–221.
   PubMed Web of Science ®Google Scholar
• Ruusuvuori E, Kaila K. Carbonic anhydrases and brain pH in the control of neuronal excitability. Subcell Biochem 2014;75:271–1290.
   PubMedGoogle Scholar
• Farrant M, Nusser Z. Variations on an inhibitory theme: Phasic and tonic activation of GABA A receptors. Nat Rev Neurosci 2005;6:215–29.
   PubMed Web of Science ®Google Scholar
• Makani S, Chen HY, Esquenazi S, et al. NMDA receptor-dependent afterdepolarizations are curtailed by carbonic anhydrase 14: Regulation of a short-term postsynaptic potentiation. J Neurosci 2012;32:16754–62.
   PubMed Web of Science ®Google Scholar
• Supuran CT. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 2008;7:168–81.
   PubMed Web of Science ®Google Scholar
• Supuran CT. Carbonic anhydrase activators. Future Med Chem 2018;10:561–73.
   PubMed Web of Science ®Google Scholar
• Provensi G, Carta F, Nocentini A, et al. A new kid on the block? Carbonic anhydrases as possible new targets in alzheimer’s disease. Int J Mol Sci 2019;20:4724.
   PubMed Web of Science ®Google Scholar
• Svichar N, Waheed A, Sly WS, et al. Carbonic anhydrases CA4 and CA14 both enhance AE3-mediated Cl-HCO3- exchange in hippocampal neurons. J Neurosci 2009;29:3252–8.
   PubMed Web of Science ®Google Scholar
• Yang MT, Chien WL, Lu DH, et al. Acetazolamide impairs fear memory consolidation in rodents. Neuropharmacology 2013;67:412–8.
   PubMed Web of Science ®Google Scholar
• Sun M-K, Alkon DL. Pharmacological enhancement of synaptic efficacy, spatial learning, and memory through carbonic anhydrase activation in rats. J Pharmacol Exp Ther 2001;297:961–7.
   PubMed Web of Science ®Google Scholar
• Supuran CT. How many carbonic anhydrase inhibition mechanisms exist? J Enzyme Inhib Med Chem 2016;31:345–60.
   PubMed Web of Science ®Google Scholar
• Temperini C, Scozzafava A, Vullo D, Supuran CT. Carbonic anhydrase activators. Activation of isoforms I, II, IV, VA, VII, and XIV with L- and D-phenylalanine and crystallographic analysis of their adducts with isozyme II: stereospecific recognition within the active site of an enzyme and its consequences for the drug design . J Med Chem 2006;49:3019–27.
   PubMed Web of Science ®Google Scholar
• Temperini C, Scozzafava A, Vullo D, Supuran CT. Carbonic anhydrase activators. Activation of isozymes I, II, IV, VA, VII, and XIV with L- and D-histidine and crystallographic analysis of their adducts with isoform II: engineering proton-transfer processes within the active site of an enzyme. Chemistry 2006;12:7057–66.
   PubMed Web of Science ®Google Scholar
• Temperini C, Innocenti A, Scozzafava A, Supuran CT. Carbonic anhydrase activators: Kinetic and X-ray crystallographic study for the interaction of d- and l-tryptophan with the mammalian isoforms I-XIV. Bioorg Med Chem 2008;16:8373–8.
   PubMed Web of Science ®Google Scholar
• Elder I, Tu C, Ming LJ, et al. Proton transfer from exogenous donors in catalysis by human carbonic anhydrase II. Arch Biochem Biophys 2005;437:106–14.
   PubMed Web of Science ®Google Scholar
• Maupin CM, Castillo N, Taraphder S, et al. Chemical rescue of enzymes: proton transfer in mutants of human carbonic anhydrase II. J Am Chem Soc 2011;133:6223–34.
   PubMed Web of Science ®Google Scholar
• Briganti F, Mangani S, Orioli P, et al. Carbonic anhydrase activators: X-ray crystallographic and spectroscopic investigations for the interaction of isozymes I and II with histamine. Biochemistry 1997;36:10384–92.
   PubMed Web of Science ®Google Scholar
• Supuran CT, Scozzafava A. Carbonic anhydrase activators: synthesis of high affinity isozymes I, II and IV activators, derivatives of 4-(arylsulfonylureido-amino acyl)ethyl-1H-imidazole. J Enzyme Inhib 2000;15:471–86.
   PubMed Web of Science ®Google Scholar
• Scozzafava A, Iorga B, Supuran CT. Carbonic anhydrase activators: Synthesis of high affinity isozymes I, II and IV activators, derivatives of 4-(4-tosylureido-amino acyl)ethyl-1H-imidazole (histamine derivatives). J Enzyme Inhib 2000;15:139–61.
   PubMed Web of Science ®Google Scholar
• Saada MC, Vullo D, Montero JL, et al. Carbonic anhydrase i and II activation with mono- and dihalogenated histamine derivatives. Bioorg Med Chem Lett 2011;21:4884–7.
   PubMed Web of Science ®Google Scholar
• Saada MC, Vullo D, Montero JL, et al. Mono- and di-halogenated histamine, histidine and carnosine derivatives are potent carbonic anhydrase I, II, VII, XII and XIV activators. Bioorg Med Chem 2014;22:4752–8.
   PubMed Web of Science ®Google Scholar
• Draghici B, Vullo D, Akocak S, et al. Ethylene bis-imidazoles are highly potent and selective activators for isozymes VA and VII of carbonic anhydrase, with a potential nootropic effect. Chem Commun 2014;50:5980–3.
   PubMed Web of Science ®Google Scholar
• Temperini C, Innocenti A, Scozzafava A, et al. Carbonic anhydrase activators: l-Adrenaline plugs the active site entrance of isozyme II, activating better isoforms I, IV, VA, VII, and XIV. Bioorg Med Chem Lett 2007;17:628–35.
   PubMed Web of Science ®Google Scholar
• Temperini C, Scozzafava A, Puccetti L, Supuran CT. Carbonic anhydrase activators: X-ray crystal structure of the adduct of human isozyme II with l-histidine as a platform for the design of stronger activators. Bioorg Med Chem Lett 2005;15:5136–41.
   PubMed Web of Science ®Google Scholar
• Temperini C, Scozzafava A, Supuran CT. Carbonic anhydrase activators: The first X-ray crystallographic study of an adduct of isoform I. Bioorg Med Chem Lett 2006;16:5152–6.
   PubMed Web of Science ®Google Scholar
• Casini A, Caccia S, Scozzafava A, Supuran CT. Carbonic anhydrase activators. The selective serotonin reuptake inhibitors fluoxetine, sertraline and citalopram are strong activators of isozymes I and II. Bioorganic Med Chem Lett 2003;13:2765–8.
   PubMed Web of Science ®Google Scholar
• Abdülkadir Coban T, Beydemir Ş, Gücin I, et al. Sildenafil is a strong activator of mammalian carbonic anhydrase isoforms I-XIV. Bioorg Med Chem 2009;17:5791–5.
   PubMed Web of Science ®Google Scholar
• Welsch ME, Snyder SA, Stockwell BR. Privileged scaffolds for library design and drug discovery. Curr Opin Chem Biol 2010;14:347–61.
   PubMed Web of Science ®Google Scholar
• Costa B, Da Pozzo E, Chelli B, et al. Anxiolytic properties of a 2-phenylindolglyoxylamide TSPO ligand: stimulation of in vitro neurosteroid production affecting GABAA receptor activity. Psychoneuroendocrinology 2011;36:463–72.
   PubMed Web of Science ®Google Scholar
• Taliani S, Cosimelli B, Da Settimo F, et al. Identification of anxiolytic/nonsedative agents among indol-3-ylglyoxylamides acting as functionally selective agonists at the gamma-aminobutyric acid-A (GABAA) alpha2 benzodiazepine receptor. J Med Chem 2009;52:3723–34.
   PubMed Web of Science ®Google Scholar
• Da Pozzo E, Giacomelli C, Costa B, et al. TSPO PIGA ligands promote neurosteroidogenesis and human astrocyte well-being. Int J Mol Sci 2016;17:1028.
   Web of Science ®Google Scholar
• Bruno A, Barresi E, Simola N, et al. Unbinding of translocator protein 18 kDa (TSPO) ligands: from in vitro residence time to in vivo efficacy via in silico simulations. ACS Chem Neurosci 2019;10:3805–14.
   PubMed Web of Science ®Google Scholar
• Santoro A, Mattace Raso G, Taliani S, et al. TSPO-ligands prevent oxidative damage and inflammatory response in C6 glioma cells by neurosteroid synthesis. Eur J Pharm Sci 2016;88:124–31.
   PubMed Web of Science ®Google Scholar
• Taliani S, Da Settimo F, Martini C, et al. Exploiting the indole scaffold to design compounds binding to different pharmacological targets. Molecules 2020;25:2331.
   Web of Science ®Google Scholar
• Robello M, Barresi E, Baglini E, et al. The alpha keto amide moiety as a privileged motif in medicinal chemistry: current insights and emerging opportunities. J Med Chem 2021;64:3508–45.
   PubMed Web of Science ®Google Scholar
• Xu XH, Liu GK, Azuma A, et al. Synthesis of indole and biindolyl triflones: Trifluoromethanesulfonylation of indoles with Tf2O/TTBP (2,4,6-tri-tert-butylpyridine) system. Org Lett 2011;13:4854–7.
   PubMed Web of Science ®Google Scholar
• Khalifah RG. The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C. J Biol Chem 1971;246:2561–73.
   PubMed Web of Science ®Google Scholar
• Pastorekova S, Vullo D, Nishimori I, et al. Carbonic anhydrase activators: Activation of the human tumor-associated isozymes IX and XII with amino acids and amines. Bioorg Med Chem 2008;16:3530–6.
   PubMed Web of Science ®Google Scholar
• Vullo D, Nishimori I, Innocenti A, et al. Carbonic anhydrase activators: An activation study of the human mitochondrial isoforms VA and VB with amino acids and amines. Bioorg Med Chem Lett 2007;17:1336–40.
   PubMed Web of Science ®Google Scholar
• Supuran C, Barboiu M, Luca C, et al. Carbonic anhydrase activators. Part 14. Syntheses of mono and bis pyridinium salt derivatives of 2-amino-5-(2-aminoethyl)-and 2-amino-5-(3-aminopropyl)-1, 3, 4- thiadiazole and their interaction with isozyme II. Eur J Med Chem 1996;31:597–606.
   Web of Science ®Google Scholar
• Provensi G, Nocentini A, Passani MB, et al. Activation of carbonic anhydrase isoforms involved in modulation of emotional memory and cognitive disorders with histamine agonists, antagonists and derivatives. J Enzyme Inhib Med Chem 2021;36:719–26.
   PubMed Web of Science ®Google Scholar
• Santos-Martins D, Solis-Vasquez L, Tillack AF, et al. Accelerating AutoDock4 with GPUs and gradient-based local search. J Chem Theory Comput 2021;17:1060–73.
   PubMed Web of Science ®Google Scholar
• Morris GM, Ruth H, Lindstrom W, et al. Software news and updates AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 2009;30:2785–91.
   PubMed Web of Science ®Google Scholar
• RCSB PDB – 3MDZ: crystal structure of human carbonic anhydrase VII [isoform 1], CA7.
   Google Scholar
• Berman HM, Westbrook J, Feng Z, et al. The protein data bank. Nucleic acids res. Oxford : Oxford University Press; 2000. p. 235–242.
   Google Scholar
• Schrödinger Release 2020-2: Protein Preparation Wizard; Epik, Schrödinger, LLC, New York, NY, 2020; Impact, Schrödinger, LLC, New York, NY; Prime, Schrödinger, LLC, New York, NY, 2020.
   Google Scholar
• Sastry GM, Adzhigirey M, Day T, et al. Protein and ligand preparation: Parameters, protocols, and influence on virtual screening enrichments. J Comput Aid Mol Des 2013;27:221–34.
   Google Scholar
• Behnke CA, Le Trong I, Godden JW, et al. Atomic resolution studies of carbonic anhydrase II. Acta Crystallogr D Biol Crystallogr 2010;66:616–27.
   PubMedGoogle Scholar
• Chiaramonte N, Bua S, Ferraroni M, Nocentini A, et al. 2-Benzylpiperazine: a new scaffold for potent human carbonic anhydrase inhibitors. Synthesis, enzyme inhibition, enantioselectivity, computational and crystallographic studies and in vivo activity for a new class of intraocular pressure lowering agents. Eur J Med Chem 2018;151:363–75.
   PubMed Web of Science ®Google Scholar
• Angeli A, Chiaramonte N, Manetti D, et al. Investigation of piperazines as human carbonic anhydrase I, II, IV and VII activators. J Enzyme Inhib Med Chem 2018;33:303–8.
   PubMed Web of Science ®Google Scholar
• Garcia-Mesa Y, Jay TR, Checkley MA, et al. Immortalization of primary microglia: a new platform to study HIV regulation in the central nervous system. J Neurovirol 2017;23:47–66.
   PubMed Web of Science ®Google Scholar
• Liu X, Lu D, Bowser R, Liu J. Expression of carbonic anhydrase I in motor neurons and alterations in ALS. Int J Mol Sci 2016;17:1820.
   Web of Science ®Google Scholar
• Halmi P, Parkkila S, Honkaniemi J. Expression of carbonic anhydrases II, IV, VII, VIII and XII in rat brain after kainic acid induced status epilepticus. Neurochem Int 2006;48:24–30.
   PubMed Web of Science ®Google Scholar
• Ghandour MS, Parkkila AK, Parkkila S, et al. Mitochondrial carbonic anhydrase in the nervous system: expression in neuronal and glial cells. J Neurochem 2000;75:2212–20.
   PubMed Web of Science ®Google Scholar
• Ruusuvuori E, Huebner AK, Kirilkin I, et al. Neuronal carbonic anhydrase VII provides GABAergic excitatory drive to exacerbate febrile seizures. Embo J 2013;32:2275–86.
   PubMed Web of Science ®Google Scholar
• Mollica A, Macedonio G, Stefanucci A, et al. Five- and six-membered nitrogen-containing compounds as selective carbonic anhydrase activators. Molecules 2017;22:2178.
   Web of Science ®Google Scholar
• De Simone G, Alterio V, Supuran CT. Exploiting the hydrophobic and hydrophilic binding sites for designing carbonic anhydrase inhibitors. Expert Opin Drug Discov 2013;8:793–810.
   PubMed Web of Science ®Google Scholar
• Pinard MA, Mahon B, McKenna R. Probing the surface of human carbonic anhydrase for clues towards the design of isoform specific inhibitors. Biomed Res Int 2015;2015:453543.
   PubMed Web of Science ®Google Scholar
• West D, Kim CU, Tu C, et al. Structural and kinetic effects on changes in the CO(2) binding pocket of human carbonic anhydrase II. Biochemistry 2012;51:9156–63.
   PubMed Web of Science ®Google Scholar
• Pettersen EF, Goddard TD, Huang CC, Couch GS, et al. UCSF Chimera-a visualization system for exploratory research and analysis. J Comput Chem 2004;25:1605–12.
   PubMed Web of Science ®Google Scholar
• Parkhurst CN, Yang G, Ninan I, et al. Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor. Cell 2013;155:1596–609.
   PubMed Web of Science ®Google Scholar
• Wu SY, Pan BS, Tsai SF, et al. BDNF reverses aging-related microglial activation. J Neuroinflammation 2020;17:210–8.
   PubMed Web of Science ®Google Scholar
• Fang W, Liao W, Zheng Y, et al. Neurotropin reduces memory impairment and neuroinflammation via BDNF/NF-ΚB in a transgenic mouse model of Alzheimer’s disease. Am J Transl Res 2019;11:1541–54.
   PubMed Web of Science ®Google Scholar
• Onodera J, Nagata H, Nakashima A, et al. Neuronal brain-derived neurotrophic factor manipulates microglial dynamics. Glia 2021;69:890–904.
   PubMed Web of Science ®Google Scholar
• Ferrini F, De Koninck Y. Microglia control neuronal network excitability via BDNF signalling. Neural Plast 2013;2013:429815.
   PubMed Web of Science ®Google Scholar
• Matthews TA, Abel A, Demme C, et al. Expression of the CHOP-inducible carbonic anhydrase CAVI-b is required for BDNF-mediated protection from hypoxia. Brain Res 2014;1543:28–37.
   PubMed Web of Science ®Google Scholar
• Mizui T, Ishikawa Y, Kumanogoh H, et al. BDNF pro-peptide actions facilitate hippocampal LTD and are altered by the common BDNF polymorphism Val66Met. Proc Natl Acad Sci USA 2015;112:E3067–E3074.
   PubMed Web of Science ®Google Scholar
• Gomes C, Ferreira R, George J, et al. Activation of microglial cells triggers a release of brain-derived neurotrophic factor (BDNF) inducing their proliferation in an adenosine A2A receptor-dependent manner: A2A receptor blockade prevents BDNF release and proliferation of microglia. J Neuroinflammation 2013;10:16–3.
   PubMed Web of Science ®Google Scholar